Impact of QRS duration on survival benefit with prophylactic implantable cardioverter-defibrillators: a meta-analysis of randomized controlled trials

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSipahi, Ilke
dc.contributor.authorChaudhry, Sunit\\-Preet S.
dc.contributor.authorIssa, Meltiady
dc.contributor.authorAmbati, Megha
dc.contributor.authorDagdelen, Sinan
dc.contributor.authorFang, James C.
dc.date.accessioned2025-10-16T15:30:07Z
dc.date.issued2015
dc.identifier.doi10.2459/JCM.0b013e3283657524
dc.identifier.otherWOS:000369512900003
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8867
dc.publisherLIPPINCOTT WILLIAMS \& WILKINS
dc.sourceJOURNAL OF CARDIOVASCULAR MEDICINE
dc.subjectECG
dc.subjectheart failure
dc.subjectimplantable cardioverter\\-defibrillator
dc.subjectsudden cardiac death
dc.titleImpact of QRS duration on survival benefit with prophylactic implantable cardioverter-defibrillators: a meta-analysis of randomized controlled trials
dc.typeReview

Dosyalar

Koleksiyonlar

WOS